- $3.32bn
- $4.54bn
- $298.43m
- 83
- 47
- 80
- 80
R2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 449 | 261 | 260 | 268 | 298 |
Cost of Revenue | |||||
Gross Profit | 289 | 203 | 195 | 192 | 205 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 388 | 200 | -46.4 | -256 | 283 |
Operating Profit | 60.7 | 61.1 | 307 | 524 | 15.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -75.6 | -23.9 | -64.4 | 996 | 1.25 |
Provision for Income Taxes | |||||
Net Income After Taxes | -76.6 | -24.5 | -65.9 | 996 | -0.623 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -212 | -274 | 414 | 788 | -46.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -212 | -274 | 414 | 788 | -46.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.4 | -0.963 | -1.6 | 8.49 | -0.411 |
Dividends per Share |